The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Ultragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.

In the modern world, maintaining a healthy lifestyle while juggling various responsibilities can be a daunting challenge.

AquaSculpt is a natural weight loss supplement created by Dr. Blaine Schilling, a top New York City doctor specializing in weight loss. It's based on an "odd ice hack" theory that helps adults of all ...

The condition is largely associated with obesity and an unhealthy diet and lifestyle ... the race to bring a NASH drug to market, but its hopes were dashed after the FDA rejected its marketing ...